A variant Australian West Nile virus (WNV) strain, WNV NSW2011 , emerged in 2011 causing an unprecedented outbreak of encephalitis in horses in south-eastern Australia. However, no human cases associated with this strain have yet been reported. Studies using mouse models for WNV pathogenesis showed that WNV NSW2011 was less virulent than the human-pathogenic American strain of WNV, New York 99 (WNV NY99 ). To identify viral genes and mutations responsible for the difference in virulence between WNV NSW2011 and WNV NY99 strains, we constructed chimeric viruses with substitution of large genomic regions coding for the structural genes, non-structural genes and untranslated regions, as well as seven individual non-structural gene chimeras, using a modified circular polymerase extension cloning method. Our results showed that the complete non-structural region of WNV NSW2011 , when substituted with that of WNV NY99 , significantly enhanced viral replication and the ability to suppress type I IFN response in cells, resulting in higher virulence in mice. Analysis of the individual non-structural gene chimeras showed a predominant contribution of WNV NY99 NS3 to increased virus replication and evasion of IFN response in cells, and to virulence in mice. Other WNV NY99 non-structural proteins (NS2A, NS4B and NS5) were shown to contribute to the modulation of IFN response. Thus a combination of non-structural proteins, likely NS2A, NS3, NS4B and NS5, is primarily responsible for the difference in virulence between WNV NSW2011 and WNV NY99 strains, and accumulative mutations within these proteins would likely be required for the Australian WNV NSW2011 strain to become significantly more virulent.
INTRODUCTION
West Nile virus (WNV) is the causative agent of West Nile encephalitis, which is the leading cause of arboviral encephalitis in the Americas. Since the outbreak of WNV in the city of New York in 1999 (caused by the WNV NY99 strain), over 41 000 human cases with 1752 deaths have been reported in the USA alone (Centers for Disease Control and Prevention, http://www.cdc.gov/westnile/ statsMaps/preliminaryMapsData). Although an antigenically similar strain of WNV, WNV KUN , is found endemically in Australia, infections with WNV KUN are usually asymptomatic (Hall et al., 2002) . But in 2011, an unprecedented outbreak of equine encephalitis occurred in southeastern Australia following heavy rainfall and severe flooding (Frost et al., 2012) , leading to a total of 982 equine cases with a case fatality rate of .9 % (Roche et al., 2013) . The virus, named WNV NSW2011 , resulted in an unusually high number of equine cases and fatalities atypical of WNV KUN infections, and produced clinical presentation in horses similar to that of WNV NY99 . However, no human cases associated with the WNV NSW2011 strain have yet been reported. WNV NSW2011 was shown to be significantly more virulent than the prototype WNV KUN strain but less virulent than the WNV NY99 strain in mice (Frost et al., 2012) , indicating that virulence of WNV strains in a mouse model of infection correlates well with their virulence in humans. Although the different ecological and epidemiological features of the WNV NSW2011 outbreak, such as a low mosquito population, have been suggested as reasons for the lack of human infections, co-circulation of Murray Valley encephalitis virus was reported in both humans and horses around the time of the WNV NSW2011 outbreak (Frost et al., 2012; Roche et al., 2013) , indicating that vector coverage was unlikely to be a factor. Therefore, differences in the viral genome between WNV NSW2011 and WNV NY99 strains are most likely to be responsible for their apparent difference in virulence for humans. WNV NSW2011 has been fully sequenced and was shown to be most closely related to the WNV KUN strain MRM61C (Frost et al., 2012) , eliminating the possibility of an incursion event of an exotic WNV strain. A total of 42 amino acid substitutions were found in WNV NSW2011 compared with WNV KUN MRM61C, with at least two previously characterized markers of WNV virulence now found in WNV NSW2011 : (1) the E 154-156 glycosylation motif (N-Y-S) (Beasley et al., 2005) , and (2) the Phe residue in NS5 codon 653, shown to contribute to type I IFN resistance (Laurent-Rolle et al., 2010) . These mutations may thus be partially responsible for the increased virulence of WNV NSW2011 compared with that of WNV KUN (Frost et al., 2012) . Previous studies comparing the virulent WNV NY99 strain with other WNV strains showed that the majority of the virulence determinants were encoded within the nonstructural (NS) region of the viral genome Beasley et al., 2004 Beasley et al., , 2002 Borisevich et al., 2006) ; however, a systematic analysis of virulence determinants between WNV NY99 and WNV NSW2011 has not been performed. Here we aimed to assess the role of viral genes in the higher virulence of WNV NY99 in a mouse model of infection by constructing a comprehensive panel of 10 WNV NY99 /WNV NSW2011 chimeras with substituted C/prM/ E, NS1-NS5, 59 untranslated region (UTR) and 39 UTR, as well as each NS gene individually. The viruses were characterized for replication efficiency and ability to induce and suppress type I IFN response in cells and for virulence in mice. Our findings showed the essential role of the WNV NY99 NS region, and in particular NS3, for enhanced virus replication, evasion of host IFN response and virulence in mice, and demonstrated that the combined contribution of NS and structural (STR) genes was required to recapitulate the high virulence of WNV NY99 in mice.
RESULTS
Generation of WNV NSW2011 /WNV NY99 chimeras using circular polymerase extension cloning (CPEC)
To generate the parental and chimeric viruses used in this study, the CPEC method was performed with the implementation of two modifications to our previously described protocol (Edmonds et al., 2013) . First, a new UTR-linker fragment was designed, devoid of bacterial regulatory sequences and significantly shorter (1073 bp) than the previously used pKUN1dXma vector fragment (4737 bp). It encodes the CMV promoter for constitutive expression in mammalian cells, a hepatitis delta virus ribozyme (HDVr) for authentic formation of the 39 UTR termini, and a polyadenylation signal for efficient termination of transcription by RNA polymerase II. The first 22 and last 22 nt of the 59 and 39 UTRs, respectively, are conserved between all WNV strains, and were incorporated into the ends of the UTR-linker to enable circularization of DNA to ensure high transfection efficiency (Cherng et al., 1999; von Groll et al., 2006) (Fig. 1a) . Secondly, the primers used for the construction of the WNV NY99 and WNV NSW2011 cDNA libraries were designed to anneal at specific gene junctions that align with viral co-and posttranslational processing sites, to enable precise viral gene substitutions. A total of 89 amino acid differences were identified between WNV NY99 and WNV NSW2011 , of which 17 were non-conserved based on the BLOSUM 62 scoring matrix (Henikoff & Henikoff, 1992) (Table 1) . To determine which genomic regions and individual genes contain potential virulence determinants, parental viruses WNV NY99 and WNV NSW2011 and 10 WNV NSW2011 / WNV NY99 chimeric viruses were generated. The STR chimera was constructed by replacing the C/prM/E genes of WNV NSW2011 with those of WNV NY99 , the NS chimera has the complete NS1 to NS5 region replaced with that of WNV NY99 , while the UTR chimera has the 59 and 39 UTRs replaced with those of WNV NY99 . Similarly, seven individual NS1-NS5 chimeras were constructed by replacing the respective NS genes of WNV NSW2011 with those of WNV NY99 (Fig. 1b) . All chimeric viruses were successfully recovered from transfected HEK293 cells, and following amplification on Vero cells all viruses were fully sequenced. Full viral genome sequencing of WNV NY99 , WNV NSW2011 , STR, NS and UTR chimeric viruses confirmed the expected sequences and did not find any adventitious mutations outside the substituted regions in the chimeric viruses. Sequencing of substituted NS genes and regions around substitutions in the individual NS chimeras validated the correct sequence in sequenced regions. We have previously shown that the CPEC protocol does not introduce unwanted mutations in the viral sequence (Edmonds et al., 2013) ; thus, the presence of these mutations in unsequenced regions in the individual NS chimeras is unlikely. (Fig. 2a) ]. Interestingly, the NS chimera produced significantly larger plaques, even larger than WNV NY99 plaques (P¡0.0001, Fig. 2b ), indicating an increased cytopathicity of the NS chimera. The STR chimera produced plaques that were significantly larger than those produced by WNV NSW2011 (P¡0.001), indicating that the WNV NY99 C/prM/E regions also contributed to enhanced viral replication and/or spread in BHK cells. No significant differences in plaque size were found between UTR chimera and WNV NSW2011 , indicating that WNV NY99 UTRs are unlikely to contribute to more efficient replication compared with WNV NSW2011 . All individual NS chimeras except NS4A produced significantly larger plaques than those produced by WNV NSW2011 (P¡0.05). However, no significant differences in plaque morphology were observed between the individual NS chimeras, except for NS4A ( Fragment 3 , n527; all with P-values .0.05).
To examine the replication efficiency of chimeric viruses in the presence or absence of ongoing host IFN response, we employed IFN response-competent WT mouse embryonic fibroblasts (MEFs) and IFN response-deficient (IFN-a/b receptor knockout, IFNAR2/2) MEFs, respectively. The lack of IFNAR eliminates antiviral activity of IFN induced during virus infection and therefore essentially eliminates antiviral response to infection, thus allowing the examination of virus replication efficiency in the absence of antiviral response. Cells infected at m.o.i. 0.1 and virus titres were determined at 0, 24, 48 and 72 h post-infection (p.i.) (Fig. 3a, b) . In WT MEFs, the NS chimera replicated to significantly higher titres than all other viruses at 48 and 72 h p.i. (P¡0.0001) and, of the individual NS chimeras, NS3 chimera replicated significantly better than WNV NSW2011 and the rest of the individual NS chimeras (Fig. 3a) . In IFN response-deficient IFNAR2/2 MEFs, WNV NY99 and NS and STR chimeras replicated most efficiently, with statistical significance obtained between NS chimera and WNV NSW2011 at 72 h p.i. The differences for the remaining viruses compared with WNV NSW2011 at 72 h p.i. were not statistically significant, despite STR chimera and WNV NY99 trending towards higher titres (Fig. 3b) . Owing to the large number of viruses, the differences between viruses that replicated with similar efficiencies were difficult to see on the graphs (Fig. 3a, b) . Therefore, virus titres at 72 h p.i. were plotted as bar charts for better clarity (Fig. 3c, d ). Interestingly, although the NS3 chimera showed significantly enhanced replication in WT MEFs (Fig. 3c) , this was not observed in IFNAR2/2 MEFs ( Fig.  3d) , suggesting that the enhanced replication conferred by WNV NY99 NS3 protein was the result of more efficient inhibition of the IFN response. On the other hand, more efficient replication of the NS and STR chimeras in IFNAR2/2 MEFs compared with WNV NSW2011 suggests that, in the absence of IFN-induced antiviral response, WNV NY99 STR, and even more so the NS regions, contribute to more efficient virus replication than corresponding WNV NSW2011 genomic regions. The highly efficient replication 
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of NS chimera in both WT and IFNAR2/2 MEFs, which significantly exceeded the replication efficiency of even parental WNV NY99 , was somewhat unexpected and suggests that perhaps the remaining STR and UTR sequences of WNV NY99 may limit otherwise exceedingly efficient virus replication conferred by the NS genes. Overall, the results in this section showed that NS and NS3 chimeras consistently replicated more efficiently than parental viruses and other chimeras, indicating that the WNV NY99 NS proteins were likely to be responsible for more efficient replication of WNV NY99 than WNV NSW2011 , and that the NS3 protein was likely to provide a major contribution to the observed phenotype.
Induction and suppression of IFN response by parental and chimeric viruses
Because of the observed enhanced replication in IFN response-competent cells by the NS and NS3 chimeras, we investigated the ability of these chimeras, as well as other chimeras, to modulate the IFN response by quantifying IFN-b and Mx1 mRNAs using quantitative reversetranscription PCR (qRT-PCR).
We (Fig. 4a, P¡0 .01), consistent with their more efficient replication in these cells (Fig. 3b, d) . Surprisingly, a significant increase in IFN-b induction was also detected in IFNAR2/2 MEFs infected with NS2A chimera compared with WNV NSW2011 and other chimeras. The result was reproducible and was clearly not influenced by the virus replication as NS2A chimera did not show enhanced replication in IFNAR2/2 MEFs (Fig. 3b, d ).
Next, we investigated the ability of each virus to suppress IFN signalling by infecting WT MEFs with m.o.i. 1 of each virus and analysing the accumulation of Mx1 mRNA by qRT-PCR. Mx1 is an IFN-stimulated gene that is commonly used to measure IFN signalling in response to infections (Hoenen et al., 2014; Holzinger et al., 2007; Pletneva et al., 2008) . Mx1 expression values were normalized to the levels of viral RNA in order to account for variations in viral replication efficiency between the viruses. Significantly lower levels of Mx1 transcript were detected in WT MEFs infected with WNV NY99 and the NS chimera compared with the level for WNV NSW2011 (P¡0.001; Fig. 4b ). Although not statistically significant, Mx1 transcripts in cells infected with the NS3 and NS5 chimeras produced at lower levels than in cells infected with the other chimeras and WNV NSW2011 (Fig. 4b ). This suggests that the NS region of WNV NY99, and primarily NS3 and NS5 proteins, is involved in enhanced inhibition of IFN signalling.
To corroborate Mx1 mRNA expression results by another assay for IFN signalling, STAT1 phosphorylation in response to IFN treatment of infected cells was examined.
The human lung carcinoma cell line (A549 cells) was used for these experiments as it is highly responsive to IFN and is readily infected by WNV (Daffis et al., 2011) . Cells were infected with parental and chimeric viruses at m.o.i. 1, and at 48 h p.i. were treated with 5000 IU Roferon-A (human IFN-a) for 30 min before cell lysates were prepared for Western blot analysis with pSTAT1-specific antibodies. Inhibition of STAT1 phosphorylation by WNV NSW2011, WNV NY99 and NS chimera were similar, while STR and UTR chimeras showed a decreased ability to inhibit STAT1 phosphorylation (Fig. 4c) , suggesting that STR genes and UTRs of WNV NY99 may be less efficient in inhibiting STAT1 phosphorylation than is WNV NSW2011 . Amongst individual NS chimeras, NS3 and NS2A chimeras appeared to be most efficient in inhibiting STAT1 phosphorylation (Fig. 4c) . To a smaller extent, NS4B and NS5 chimeras were also shown to be able to inhibit STAT1 phosphorylation, while NS1, NS2B and NS4A chimeras were less efficient in inhibiting STAT1 phosphorylation (Fig. 4c) .
In summary, the results obtained in this section suggest that a delicate balance between the ability of the virus to induce IFN and to inhibit its antiviral activity is likely to be Y. X. Setoh and others required to determine its overall replication efficiency in IFN response-competent cells.
Resistance of parental and chimeric viruses to IFN-induced antiviral state
To further investigate the ability of chimeric viruses to infect and replicate in cells with an already established antiviral state induced by IFN, we employed IFN regulatory factor (IRF) 3-and IRF7-deficient MEFs (IRF32/2 6IRF72/2 MEFs) pretreated with mouse IFN-b. IRF32/26IRF72/2 MEFs can respond to IFN but are unable to produce IFN, which allows elimination of any antiviral effect of endogenous IFN produced in response to virus infection. IRF32/26IRF72/2MEFs were first treated with 10 IU ml 21 mouse IFN-b for 16 h, then infected with m.o.i. 1 parental and chimeric viruses, and culture supernatant at 48 h p.i. was titrated to determine virus titres. Although not statistically significant, the NS chimera replicated most efficiently in IFN-b pre-treated cells, followed by WNV NY99 , NS3 and NS2A chimeras at 48 h p.i. (Fig. 5) . The results suggest that the WNV NY99 NS region, with NS3 and NS2A likely to provide the main contribution, is involved in overcoming the IFN-induced antiviral state in cells.
Virulence of parental and chimeric viruses in mice
Our previous experiments showed that intraperitoneal infection of 4-week-old mice with 1000 p.f.u. WNV NY99 resulted in 80-90 % mortality , while the same dose of WNV NSW2011 in 4-week-old mice resulted in 60-70 % mortality (Frost et al., 2012) . To better distinguish virulence between the parental and chimeric viruses, we infected slightly older (5-week-old) mice at a dose of 1000 p.f.u.. A pilot experiment was conducted in 5-week-old mice with this dose and showed that parental WNV NSW2011 was significantly less virulent under these conditions (data not shown). As expected, WNV NY99 was the most virulent (80 % mortality), followed by the NS chimera (60 % mortality), both of which were significantly more virulent than the rest of the viruses as analysed by log-rank (Mantel-Cox) test (P¡0.05) (Fig. 6 ). The survival rates between WNV NY99 -and NS chimera-infected groups ). Virus titres at 72 h p.i. in WT MEFs (c) and IFNAR"/" MEFs (d) were plotted on a bar chart to better illustrate the differences between viruses. Statistical analysis was performed by one-way ANOVA comparing WNV NY99 and main chimeras (STR, NS, UTR) against WNV NSW2011 , and individual NS chimeras (NS1-NS5) against WNV NSW2011 . **, P¡0.01; ***, P¡0.001; ****, P¡0.0001. Error bars indicate mean±SEM.
were not significantly different. It was also noted that infection with NS chimera resulted in a delayed time-todeath compared with WNV NY99 (approximately 3 days later than WNV NY99 ), although the difference was not statistically significant (Fig. 6) . Infection with the NS3 chimera resulted in 20 % mortality, while infection with WNV NSW2011 , and STR, NS2A, NS2B and NS5 chimeras all resulted in 10 % mortality (Fig. 6) . Infection with the UTR, NS1, NS4A and NS4B chimeras did not result in any mortality (Fig. 6) . Overall, virulence in mice correlated with in vitro results, showing that the most efficiently replicating viruses, with enhanced suppression of IFN response (e.g. WNV NY99 , NS chimera and NS3 chimera), were also virulent in mice.
DISCUSSION
Although WNV KUN and WNV NY99 share approximately 98 % identity at the amino acid level (Lanciotti et al., 2002) , WNV KUN signalling the potential emergence of human-virulent WNV KUN strains in Australia in the future (Prow, 2013) . This study aimed at systematic analysis of potential virulence determinants between WNV NSW2011 and WNV NY99 strains by generating a panel of 10 chimeric viruses with precise substitutions of viral genomic regions and individual genes, and characterizing their replication and virulence properties in mice.
Our data demonstrated that the NS coding region provided a major contribution to more efficient replication of WNV NY99 in cells and higher virulence in mice. Although significant enhancement in viral replication in cells and virulence in mice was observed for the NS chimera, some delay in the time-to-death and a relatively reduced mortality were observed in mice infected with the NS chimera compared with WNV NY99 . We hypothesize that this residual attenuation is likely to be attributable to the WNV NSW2011 STR genes. Interestingly, substitution with WNV NY99 STR proteins (STR chimera) resulted in enlarged plaques and improved growth in IFN responsedeficient cell lines (BHK and IFNAR2/2 MEFs, respectively) compared with WNV NSW2011 , suggesting that WNV NY99 STR proteins are more efficient in supporting virus replication in the absence of antiviral response. On the other hand, in IFN response-competent cells, the STR chimera replicated less efficiently, resulted in higher induction of Mx1, and was inefficient in the inhibition of STAT1 phosphorylation, suggesting that the WNV NY99 STR proteins were less efficient than WNV NSW2011 STR proteins in the inhibition of IFN response. Thus, an interaction between the STR and NS domains appears to be important in providing a delicate balance that determines the outcome of infection with the WNV NY99 strain, whereby decreased ability of STR genes to inhibit IFN signalling counteracts the exceedingly high ability of NS genes to enhance virus replication and inhibit IFN response.
Comparative analysis of replication efficiencies of parental and chimeric viruses in IFN response-deficient (IFNAR2/2) MEFs demonstrated that WNV NY99 NS proteins and, to a lesser degree, STR proteins provided advantage to the replication of corresponding chimeric viruses. This indicates that, in the absence of antiviral IFN response, both NS and STR genomic regions are able to confer an advantage to virus replication. In contrast, only NS and NS3 chimeras replicated more efficiently in IFN response-competent WT MEFs. While enhanced replication of NS chimera in WT MEFs was anticipated from its significantly higher replication efficiency in IFNAR2/2 MEFs, the enhanced replication of the NS3 chimera compared with the parental WNV NSW2011 and other individual NS chimeras was somewhat unexpected and clearly pointed towards the role of WNV NY99 NS3 in more efficient inhibition of antiviral IFN response. Further analyses revealed that WNV NY99 NS3 protein indeed conferred enhanced inhibition of IFN signalling and increased ability to overcome the IFN-induced antiviral state in cells, as well as increased virulence in mice.
Sequence alignment of the NS3 gene revealed that 10 out of a total of 12 amino acid substitutions between WNV NSW2011 and WNV NY99 NS3, including all three non-conserved changes (A249P, I356T, C486F), are located in the helicase domain (Table 1 ). The helicase domain of WNV NS3 was also previously associated with resistance against the antiviral activity of Oas1b (Mertens et al., 2010) . Survival of 5-week-old CD1 mice after infection with parental and chimeric viruses. Five-week-old Swiss outbred CD1 mice were infected with 1000 p.f.u. of the indicated viruses via the intraperitoneal route and monitored for signs of encephalitis for 21 days p.i. Statistical analysis was performed using the log-rank (Mantel-Cox) test compared against the WNV NSW2011 -infected group. *, P¡0.05; **, P¡0.01.
increase in replication of the NS3 chimera in IFN responsecompetent cells but not in IFN response-deficient cells could suggest that WNV NY99 NS3 may be more efficient in inhibiting Oas1b antiviral activity. Although the NS3-S365G mutant identified in the previous study did not appear to directly affect the ability of the virus to resist antiviral activity of Oas1b, a marked increase in viral RNA replication in Oas1b-expressing cells was noted (Mertens et al., 2010) . Notably, one of the three non-conserved changes in NS3 between WNV NSW2011 and WNV NY99 is the A249P substitution, which was previously shown to enhance virus growth in American crows and was strongly associated with increased pathogenesis (Brault et al., 2007) . Based on the WNV KUN NS3 helicase crystal structure (Mastrangelo et al., 2007) , the A249 residue is located within a flexible loop in domain I of the helicase. It is interesting to note that during dsRNA unwinding, it is proposed that the negative-sense strand passes along the side of the protein where the A249 residue sits (Kim et al., 1998; Yamashita et al., 2008) . The second non-conservative difference in NS3 between WNV NSW2011 and WNV NY99 (I356T) lies proximal to two regions of interest, the NS3 motif IV (corresponding to WNV NSW2011 NS3 residues 360-368), proposed to be important for RNA translocation through the helicase in response to NTP hydrolysis (Mertens et al., 2010; Wu et al., 2005) , and also the W349A mutation in yellow fever virus (corresponding to WNV NSW2011 NS3 residue 345), shown to be essential for virus particle assembly (Patkar & Kuhn, 2008) . Furthermore, I356 is also located proximal to S365, shown to be important for resistance against the antiviral activity of Oas1b (Mertens et al., 2010) . The third non-conservative change between WNV NSW2011 and WNV NY99 , C486F, is found on the opposite face of the protein with reference to A249, and sits in the inter-domain region between domains I and II of NS3. This face of the protein is proposed to accommodate the path of the positive-sense RNA strand during unwinding (Kim et al., 1998; Yamashita et al., 2008) . Furthermore, a D483 deletion in the NS3 helicase domain was shown to render WNV more sensitive to IFN response (Ebel et al., 2011) . Further studies should focus on how individual amino acid differences in NS3 between WNV NSW2011 and WNV NY99, particularly A249P, I356T and C486F, affect the ability of the mutant viruses to inhibit Oas1b and/or other factors in the host IFN response to facilitate more efficient virus replication and increased mortality.
Our investigation into the NS2A chimera revealed an unexpected and significant increase in the induction of IFN-b in IFNAR2/2 MEFs compared with the parental WNV NSW2011 and with other individual NS chimeras. This result was consistent and observed in all the experiments. At the same time, the NS2A chimera showed notably increased resistance to the antiviral activity of IFN in a pretreatment experiment, and an efficient inhibition of STAT1 phosphorylation in response to IFN post-treatment. The NS2A chimera, however, did not exhibit more efficient replication in cells or higher virulence in mice than did WNV NSW2011 , suggesting perhaps that the enhanced ability of the NS2A chimera to inhibit IFN may be counteracted by its initial enhanced induction of IFN, resulting in a largely unaltered viral phenotype. One hypothesis is that the functions of NS2A in transporting viral RNA to RNA replication and/or virus assembly sites (Roby et al., 2012) could be altered, leading to the exposure of viral RNA to pattern recognition receptors, resulting in higher induction of IFN-b expression.
In streptomycin. HEK293 cells were maintained in DMEM supplemented with 10 % FBS, 10 U ml 21 penicillin, 10 mg ml 21 streptomycin and 1 mM sodium pyruvate. A549 cells were maintained in DMEM/ F12 medium supplemented with 10 % FBS, 10 U ml 21 penicillin and 10 mg ml 21 streptomycin. All cells were grown in a 37 uC / 5 % CO 2 incubator.
Generation of parental and chimeric viruses by CPEC. The primer sets used for the generation of the WNV NY99 and WNV NSW2011 cDNA libraries are detailed in Table S1 (available in the online Supplementary Material). The WNV NY99 isolate 4132 cDNA library was generated by PCR amplification using ligated DNA from our previously generated two-plasmid system as the template, while the cDNA library of WNV NSW2011 was generated by RT-PCR from a stock of WNV NSW2011 isolated from the brain of an infected horse passaged once in C6/36 cells (Frost et al., 2012) . For each CPEC assembly, 0.06 pmol of each viral cDNA fragment was added to the Phusion HF reaction (NEB) according to the manufacturer's instructions. Thermal cycling was carried out at 98 uC for 2 min (one cycle), 98 uC for 30 s, 60 uC for 30 s, 72 uC for 2 min 30 s (ten cycles), 98 uC for 30 s, 60 uC for 30 s, 72 uC for 5 min (ten cycles), and 98 uC for 30 s, 60 uC for 30 s, 72 uC for 8 min (10 cycles). The CPEC reaction was purified using the Wizard SV Gel and PCR Clean-Up System (Promega), and eluted in 50 ml DEPC H 2 O. The entire 50 ml CPEC reaction was transfected into HEK293 cells using Lipofectamine LTX (Invitrogen) in a six-well plate. Four to five days post-transfection, the HEK293 cell culture supernatants (2 ml) were harvested and stored at 280 uC (passage 0 stock). For the generation of passage 1 stocks for experimental use, Vero cells in T75 flasks were infected with 200 ml of the passage 0 stocks, and harvested 3-5 days post-infection, when cytopathic effect was observed. The culture supernatant was clarified from cell debris by centrifugation and titrated by plaque assay on BHK cells. The resulting viruses in passage 1 virus stocks were sequenced, and used for all subsequent experiments.
Plaque assay. BHK cells were seeded into six-well plates and infected with 10-fold serial dilutions of virus samples for 1 h at 37 uC, after which 2 ml 0.75 % low-melting-point agarose in DMEM supplemented with 2 % FBS was overlaid onto the cells and allowed to solidify before placing the plates back into the 37 uC CO 2 incubator. Three days p.i., the cells were fixed with 4 % formaldehyde for 30 min at room temperature. The agar overlay was then removed and the fixed cells were stained with 0.2 % crystal violet solution to reveal the plaques.
Growth kinetics. WT or IFNAR2/2 MEF cells were seeded into sixwell plates at a density of 3610 5 cells per well. The following day, cells were infected at m.o.i. 0.1 and culture supernatant was harvested at 0, 24, 48 and 72 h p.i. Viral titres were determined by plaque assay. Two independent experiments were conducted.
qRT-PCR. WT or IFNAR2/2 MEF cells were seeded into 12-well plates at 1.2610 5 cells per well and infected the next day at m.o.i. 1. At 48 h p.i., the infected cells were washed three times with PBS and lysed in TRI Reagent LS (Sigma-Aldrich). For each sample, 1 mg RNA was used as template for reverse transcription using the qScript cDNA Synthesis kit (Quanta Biosciences). The qRT-PCR was set up using the SYBR Green PCR Master Mix (Invitrogen) with the primer sets listed in Table S2 . The qRT-PCR data were converted to relative quantification by normalizing the C T values of each target gene (Ifnb1, Mx1, viral RNA) against the endogenous control Tbp1 (DC T ), and the mock sample (DDC T ). DDC T values of Ifnb1 and Mx1 were then normalized to viral RNA from the same sample. Results were expressed as fold change compared to mock (2
2DDCT
). Two independent experiments were conducted, and qRT-PCR was performed in triplicate.
Western blot. Cell lysates were prepared in BS9 lysis buffer (120 mM NaCl, 50 mM H 3 BO 3 , 1 % Triton X-100 and 0.1 % SDS, pH 9.0) and then diluted in 46 NuPage LDS sample buffer (Invitrogen) and heated at 95 uC for 5 min. The proteins were separated by SDS-PAGE (4-12 % precast gradient polyacrylamide gels; Invitrogen) at 175 V for 30 min, and transferred onto a nitrocellulose membrane (Amersham Biosciences) at 100 V for 1 h. Membranes were probed with p-STAT1, STAT1, anti-E or GAPDH antibodies diluted in PBS containing 0.05 % Tween 20 (PBS-T).
Virulence in mice. All animal procedures had received prior approval from the University of Queensland Animal Ethics Committee in accordance with the guidelines for animal experimentation as set out by the National Health and Medical Research Council, Australia. Swiss outbred mice (5 weeks old) (Animal Resources Centre) were infected via the intraperitoneal route with viruses at a dose of 1000 p.f.u. determined by plaque assay on Vero cells. Five mice per group were infected with each virus for the first experiment, and another five for the second experiment. Data from the two independent experiments were pooled (total of 10 mice per group). Infected animals were monitored daily for 21 days p.i., and at the first signs of encephalitis (severe hunching, lethargy, eye closure, severe twitching or hind-leg flaccid paralysis) were immediately culled.
Statistical analyses. An ordinary one-way ANOVA followed by multiple comparison was performed using GraphPad Prism 6.0 software. Survival curves were analysed using the log-rank (MantelCox) test (GraphPad).
